Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 243

1.

Rotavirus vaccination within the South African Expanded Programme on Immunisation.

Seheri LM, Page NA, Mawela MP, Mphahlele MJ, Steele AD.

Vaccine. 2012 Sep 7;30 Suppl 3:C14-20. doi: 10.1016/j.vaccine.2012.04.018. Review.

PMID:
22939015
2.

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.

Madhi SA, Kirsten M, Louw C, Bos P, Aspinall S, Bouckenooghe A, Neuzil KM, Steele AD.

Vaccine. 2012 Apr 27;30 Suppl 1:A44-51. doi: 10.1016/j.vaccine.2011.08.080.

PMID:
22520136
3.

Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.

Pawinski R, Debrus S, Delem A, Smolenov I, Suryakiran PV, Han HH.

J Infect Dis. 2010 Sep 1;202 Suppl:S80-6. doi: 10.1086/653547.

4.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
5.

Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.

Nakagomi O, Iturriza-Gomara M, Nakagomi T, Cunliffe NA.

Expert Opin Biol Ther. 2013 Nov;13(11):1613-21. doi: 10.1517/14712598.2013.840285. Epub 2013 Oct 2. Review.

PMID:
24088009
6.

Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial.

Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, Chimpeni P, Victor JC, Steele AD, Bouckenooghe A, Neuzil KM.

Vaccine. 2012 Apr 27;30 Suppl 1:A36-43. doi: 10.1016/j.vaccine.2011.09.120.

7.

Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium.

Parashar U, Steele D, Neuzil K, Quadros Cd, Tharmaphornpilas P, Serhan F, Santosham M, Patel M, Glass R.

Expert Rev Vaccines. 2013 Feb;12(2):113-7. doi: 10.1586/erv.12.148.

PMID:
23414403
8.

Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.

Amador JJ, Vasquez J, Orozco M, Pedreira C, Malespin O, De Oliveira LH, Tate J, Parashar U, Patel M.

Int J Infect Dis. 2010 Jul;14(7):e592-5. doi: 10.1016/j.ijid.2009.08.014. Epub 2009 Dec 22.

9.

Effect of human rotavirus vaccine on severe diarrhea in African infants.

Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM.

N Engl J Med. 2010 Jan 28;362(4):289-98. doi: 10.1056/NEJMoa0904797.

10.

Rotarix®: vaccine performance 6 years postlicensure.

O'Ryan M, Lucero Y, Linhares AC.

Expert Rev Vaccines. 2011 Dec;10(12):1645-59. doi: 10.1586/erv.11.152. Review.

PMID:
22085167
11.

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.

Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd S, Louw C, Kirsten M, Aspinall S, Van Doorn LJ, Bouckenooghe A, Suryakiran PV, Han HH.

BMC Infect Dis. 2012 Sep 13;12:213. doi: 10.1186/1471-2334-12-213.

12.

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.

Tate JE, Patel MM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD.

Expert Rev Vaccines. 2012 Feb;11(2):211-20. doi: 10.1586/erv.11.184. Review.

PMID:
22309669
13.

Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.

Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, Racz ML.

Pediatr Infect Dis J. 2010 Nov;29(11):1019-22. doi: 10.1097/INF.0b013e3181e7886a.

PMID:
20543761
14.

Rotavirus vaccines: update on global impact and future priorities.

Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD.

Hum Vaccin. 2011 Dec;7(12):1282-90. doi: 10.4161/hv.7.12.18321. Epub 2011 Dec 1. Review.

15.

Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.

Breiman RF, Zaman K, Armah G, Sow SO, Anh DD, Victor JC, Hille D, Ciarlet M, Neuzil KM.

Vaccine. 2012 Apr 27;30 Suppl 1:A24-9. doi: 10.1016/j.vaccine.2011.08.124.

PMID:
22520132
16.

Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.

Tapia MD, Armah G, Breiman RF, Dallas MJ, Lewis KD, Sow SO, Rivers SB, Levine MM, Laserson KF, Feikin DR, Victor JC, Ciarlet M, Neuzil KM, Steele AD.

Vaccine. 2012 Apr 27;30 Suppl 1:A79-85. doi: 10.1016/j.vaccine.2012.01.022.

PMID:
22520141
17.

Report of the 7th African Rotavirus Symposium, Cape Town, South Africa, 8th November 2012.

Seheri LM, Mwenda JM, Page N.

Vaccine. 2014 Nov 12;32(48):6336-41. doi: 10.1016/j.vaccine.2014.05.002. Epub 2014 May 14.

PMID:
24837779
18.
19.
20.

Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review.

Desai R, Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM.

Mem Inst Oswaldo Cruz. 2011 Dec;106(8):907-11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk